Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Other financing activities (2022 - 2024)

Cosmos Health (COSM) has disclosed Other financing activities for 3 consecutive years, with -$124390.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other financing activities fell 117.33% year-over-year to -$124390.0, compared with a TTM value of $372110.0 through Mar 2025, down 60.91%, and an annual FY2024 reading of $391575.0, down 45.45% over the prior year.
  • Other financing activities was -$124390.0 for Q4 2024 at Cosmos Health, down from $264750.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.0 million in Q4 2022 and bottomed at -$124390.0 in Q4 2024.
  • Average Other financing activities over 3 years is $410796.9, with a median of $109636.0 recorded in 2023.
  • The sharpest move saw Other financing activities surged 1976.04% in 2023, then crashed 117.33% in 2024.
  • Year by year, Other financing activities stood at $3.0 million in 2022, then plummeted by 75.93% to $717888.0 in 2023, then crashed by 117.33% to -$124390.0 in 2024.
  • Business Quant data shows Other financing activities for COSM at -$124390.0 in Q4 2024, $264750.0 in Q3 2024, and $231750.0 in Q2 2024.